These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 17442890)
1. A Mutation in the SH2 domain of STAT2 prolongs tyrosine phosphorylation of STAT1 and promotes type I IFN-induced apoptosis. Scarzello AJ; Romero-Weaver AL; Maher SG; Veenstra TD; Zhou M; Qin A; Donnelly RP; Sheikh F; Gamero AM Mol Biol Cell; 2007 Jul; 18(7):2455-62. PubMed ID: 17442890 [TBL] [Abstract][Full Text] [Related]
2. Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells. Schaber JD; Fang H; Xu J; Grimley PM; Rui H Cancer Res; 1998 May; 58(9):1914-9. PubMed ID: 9581833 [TBL] [Abstract][Full Text] [Related]
3. Heartland virus antagonizes type I and III interferon antiviral signaling by inhibiting phosphorylation and nuclear translocation of STAT2 and STAT1. Feng K; Deng F; Hu Z; Wang H; Ning YJ J Biol Chem; 2019 Jun; 294(24):9503-9517. PubMed ID: 31040183 [TBL] [Abstract][Full Text] [Related]
4. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells. Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668 [TBL] [Abstract][Full Text] [Related]
5. Identification of a novel conserved motif in the STAT family that is required for tyrosine phosphorylation. Gamero AM; Sakamoto S; Montenegro J; Larner AC J Biol Chem; 2004 Mar; 279(13):12379-85. PubMed ID: 14722125 [TBL] [Abstract][Full Text] [Related]
6. IFN-type-I-mediated signaling is regulated by modulation of STAT2 nuclear export. Frahm T; Hauser H; Köster M J Cell Sci; 2006 Mar; 119(Pt 6):1092-104. PubMed ID: 16507591 [TBL] [Abstract][Full Text] [Related]
7. Functional subdomains of STAT2 required for preassociation with the alpha interferon receptor and for signaling. Li X; Leung S; Kerr IM; Stark GR Mol Cell Biol; 1997 Apr; 17(4):2048-56. PubMed ID: 9121453 [TBL] [Abstract][Full Text] [Related]
8. A Positive Feedback Amplifier Circuit That Regulates Interferon (IFN)-Stimulated Gene Expression and Controls Type I and Type II IFN Responses. Michalska A; Blaszczyk K; Wesoly J; Bluyssen HAR Front Immunol; 2018; 9():1135. PubMed ID: 29892288 [TBL] [Abstract][Full Text] [Related]
9. Role of the STAT1-SH2 domain and STAT2 in the activation and nuclear translocation of STAT1. Mowen K; David M J Biol Chem; 1998 Nov; 273(46):30073-6. PubMed ID: 9804758 [TBL] [Abstract][Full Text] [Related]
10. STAT1 N-terminal domain discriminatively controls type I and type II IFN signaling. Göder A; Ginter T; Heinzel T; Stroh S; Fahrer J; Henke A; Krämer OH Cytokine; 2021 Aug; 144():155552. PubMed ID: 34000478 [TBL] [Abstract][Full Text] [Related]
11. The SH2 domains of Stat1 and Stat2 mediate multiple interactions in the transduction of IFN-alpha signals. Gupta S; Yan H; Wong LH; Ralph S; Krolewski J; Schindler C EMBO J; 1996 Mar; 15(5):1075-84. PubMed ID: 8605877 [TBL] [Abstract][Full Text] [Related]
12. In silico simulations of STAT1 and STAT3 inhibitors predict SH2 domain cross-binding specificity. Szelag M; Sikorski K; Czerwoniec A; Szatkowska K; Wesoly J; Bluyssen HA Eur J Pharmacol; 2013 Nov; 720(1-3):38-48. PubMed ID: 24211327 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of interferon signaling by rabies virus phosphoprotein P: activation-dependent binding of STAT1 and STAT2. Brzózka K; Finke S; Conzelmann KK J Virol; 2006 Mar; 80(6):2675-83. PubMed ID: 16501077 [TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of STAT2 on serine-734 negatively regulates the IFN-α-induced antiviral response. Steen HC; Kotredes KP; Nogusa S; Harris MY; Balachandran S; Gamero AM J Cell Sci; 2016 Nov; 129(22):4190-4199. PubMed ID: 27802159 [TBL] [Abstract][Full Text] [Related]
15. Differential regulation of Tetraodon nigroviridis Mx gene promoter activity by constitutively-active forms of STAT1, STAT2, and IRF9. Cheng CH; Chou CM; Chu CY; Chen GD; Lien HW; Hwang PP; Chang MS; Huang CJ Fish Shellfish Immunol; 2014 May; 38(1):230-43. PubMed ID: 24680831 [TBL] [Abstract][Full Text] [Related]
16. Role of STAT2 in the alpha interferon signaling pathway. Leung S; Qureshi SA; Kerr IM; Darnell JE; Stark GR Mol Cell Biol; 1995 Mar; 15(3):1312-7. PubMed ID: 7532278 [TBL] [Abstract][Full Text] [Related]
17. Global changes in STAT target selection and transcription regulation upon interferon treatments. Hartman SE; Bertone P; Nath AK; Royce TE; Gerstein M; Weissman S; Snyder M Genes Dev; 2005 Dec; 19(24):2953-68. PubMed ID: 16319195 [TBL] [Abstract][Full Text] [Related]
18. Interferon-gamma inhibits interferon-alpha signalling in hepatic cells: evidence for the involvement of STAT1 induction and hyperexpression of STAT1 in chronic hepatitis C. Radaeva S; Jaruga B; Kim WH; Heller T; Liang TJ; Gao B Biochem J; 2004 Apr; 379(Pt 1):199-208. PubMed ID: 14690454 [TBL] [Abstract][Full Text] [Related]
19. Enterovirus 71 inhibits cellular type I interferon signaling by downregulating JAK1 protein expression. Liu Y; Zhang Z; Zhao X; Yu R; Zhang X; Wu S; Liu J; Chi X; Song X; Fu L; Yu Y; Hou L; Chen W Viral Immunol; 2014 Aug; 27(6):267-76. PubMed ID: 24905060 [TBL] [Abstract][Full Text] [Related]
20. A conserved IFN-alpha receptor tyrosine motif directs the biological response to type I IFNs. Zhao W; Lee C; Piganis R; Plumlee C; de Weerd N; Hertzog PJ; Schindler C J Immunol; 2008 Apr; 180(8):5483-9. PubMed ID: 18390731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]